Stockreport
Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow [Yahoo! Finance]
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Amgen beat analysts' revenue expectations last quarter, reporting revenues of $9.87 billion, up 8.6% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' revenue estimates and full-year revenue guidance beating analysts' expectations. Is Amgen a buy or sell going into earnings? Read our full analysis here, it's free for active Edge members This quarter, the market is expecting Amgen's revenue to grow 4.3% year on year, slowing from the 10% increase it recorded in the same quarter last year. Amgen Total Revenue Heading into earnings, analysts covering the company have grown increasingly bullish with revenue estimates seeing in majority upward revisions over the last 30 days. Amgen has missed Wall Street's revenue estimates multiple times over the last two years. Looking at Amgen's peers in the biotechnology segment, only Incyte has reported results so far. It exceeded analysts' revenue estimates, delivering year-on-year sales growt
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INCY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INCY alerts
INCY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
NEWS
NEWS
- Incyte (INCY) had its price target raised by Stifel Nicolaus from $120.00 to $123.00. They now have a "buy" rating on the stock.[MarketBeat]
- Incyte (INCY) had its "market perform" rating reaffirmed by Oppenheimer Holdings, Inc..[MarketBeat]
- Incyte to Present at Upcoming Investor Conferences[Business Wire]
- Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising ... [Yahoo! Finance][Yahoo! Finance]
- Incyte (INCY) Beats Q1 Earnings and Revenue Estimates [Yahoo! Finance][Yahoo! Finance]
- More
INCY
SEC Filings
SEC Filings
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form ARS
- 4/28/26 - Form DEF
- INCY's page on the SEC website
- More